Item 8.01. Other Events.

On June 24, 2021, Applied Genetic Technologies Corporation issued a press release reporting 12-month data from its ongoing phase 1/2 Achromatopsia (ACHM) clinical trials. A copy of this press release is attached to this Current Report on Form 8-K asExhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.



              Exhibit No.   Description

              99.1            Press release dated June 24, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses